State Street SPDR S&P Bio... (XBI)
NYSEArca: XBI
· Precio en tiempo real · USD
160.11
+0.58 (0.36%)
Al cierre: Aug 18, 2026, 3:59 PM
State Street SPDR S&P Biotech ETF (XBI) ETF Price, Holdings & Analysis
0.36% (1D)
| Precio de compra | 0 |
| Capitalización de mercado | n/a |
| AUM | 9.63B |
| NAV | 159.47 |
| Beta | 1.14 |
| EPS (ttm) | n/a |
| Relación PE (ttm) | n/a |
| Acciones en circulación | n/a |
| Fecha de inicio | Jan 31, 2006 |
| Precio de venta | 160.6 |
| Volumen | 6,285,192 |
| Volumen medio (20D) | 8,752,762 |
| Abierto | 158.34 |
| Cierre anterior | 159.53 |
| Rango del día | 157.88 - 160.59 |
| Rango de 52 semanas | 88.18 - 165.71 |
| Participaciones | n/a |
| Relación de gastos | 0.35% |
Acerca de XBI
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").
Clase de activo Equity
Símbolo bursátil XBI
Fecha de inicio Jan 31, 2006
Proveedor State Street Investment Management
Sitio web Página de inicio del fondo
Intercambio NYSEArca
Las 10 principales participaciones 13.97% de activos
| Nombre | Símbolo | Peso |
|---|---|---|
| Apogee Therapeutics ... | APGE | 1.65% |
| Oruka Therapeutics I... | ORKA | 1.53% |
| Dianthus Therapeutic... | DNTH | 1.42% |
| Erasca Inc | ERAS | 1.38% |
| Twist Bioscience Cor... | TWST | 1.37% |
| Kymera Therapeutics ... | KYMR | 1.34% |
| Spyre Therapeutics I... | SYRE | 1.33% |
| Revolution Medicines... | RVMD | 1.32% |
| Cg Oncology Inc | CGON | 1.32% |
| Protagonist Therapeu... | PTGX | 1.31% |
Dividendos Rendimiento de dividendos 0.36%
| Ex-Dividendo | Cantidad | Fecha de pago |
|---|---|---|
| Jun 22, 2026 | $0.1380 | n/a |
| Dec 22, 2025 | $0.4070 | n/a |
| Sep 22, 2025 | $0.0270 | n/a |
| Jun 23, 2025 | $0.0070 | n/a |
| Mar 24, 2025 | $0.0050 | n/a |
Página 1 de 2